5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors

Journal of Medicinal Chemistry

Volumn 42, Issue 8, 1999, Pages 1384-1392

  De Zwart, Maarten ^a   Kourounakis, Angeliki ^a   Kooijman, Huub ^b   Spek, Anthony L ^b   Link, Regina ^a   Von Frijtag Drabbe Künzel, Jacobien K ^a   IJzerman, Ad P ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5' N (N PROPYL)CARBOXAMIDOADENOSINE; 5' N CYCLOPENTYLCARBOXAMIDOADENOSINE; 5' N CYCLOPROPYLTHIOCARBOXAMIDOADENOSINE; 5' N ETHYLTHIOCARBOXAMIDOADENOSINE; 5' N METHOXYLCARBOXAMIDOADENOSINE; ADENOSINE 5' (N METHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DERIVATIVE; ADENOSINE RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN CORTEX; CRYSTAL STRUCTURE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HYDROGEN BOND; LIGAND BINDING; NONHUMAN; RAT; RECEPTOR BINDING;

ADENOSINE; ANIMALS; CELL LINE; CEREBRAL CORTEX; CHO CELLS; CORPUS STRIATUM; CRICETINAE; CRYSTALLOGRAPHY, X-RAY; CYCLIC AMP; HUMANS; MOLECULAR CONFORMATION; RADIOLIGAND ASSAY; RATS; RECEPTORS, PURINERGIC P1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033594327     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9804984     Document Type: Article

References (48)

1. Olsson, R. A.; Pearson, J. D. Cardiovascular purinoceptors. Phys. Rev. 1960, 70, 761-845.
2. 2) receptors. In: Comprehensive Medicinal Chemistry, Volume 3: Membranes & Receptors; Emmett, J. C., Ed.; Pergamon Press: Oxford, New York, 1990.
3. 3 receptors. J. Immunol. 1997, 158, 5400-5408.
4. 2 receptors on rat Kupffer cells. Hepatology 1994, 19, 1445-1452.
5. 3 adenosine receptors. J. Immunol. 1996, 156, 3435-3442.
6. 3 receptor agonists inhibit macrophage tumor necrosis factor alpha production. Drug Dev. Res. 1996, 39, 388-392.
7. Ribeiro, J. A. Purinergic inhibition of neurotransmitter release in the central nervous system. Pharmacol. Toxicol. 1995, 77, 299-305.
8. Olah, M. E.; Stiles, G. L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 1995, 35, 581-606.
9. Jacobson, K. A.; van Galen, P. J. M.; Williams, M. Adenosine receptors: pharmacology, structure acticivity relationships and therapeutic potential. J. Med. Chem. 1992, 35, 407-422.
10. 3 adenosine receptors. J. Med. Chem. 1994, 37, 3614-3621.
11. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 978-982.
12. 3 receptor. J. Med. Chem. 1996, 39, 4142-4148.
13. 3 receptor ligands. 1. 3-(2-Pyridinyl)isoquinoline derivatives. J. Med. Chem. 1998, 41, 3987-3993.
14. 3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds. J. Med. Chem. 1998, 41, 3994-4000.
15. 3 receptor subtypes. J. Med. Chem. 1998, 41, 2835-2845.
16. 3H]-NECA in rat striatal membranes. Mol. Pharmacol. 1986, 29, 331-346.
17. 3-selective adenosine receptor agonists. J. Med. Chem. 1994, 37, 636-646.
18. Klotz, K. N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B. B.; Lohse, M. J. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 1998, 357, 1-9.
19. 2B receptor: a search for potent agonists. Nucleosides Nucleotides 1998, 17, 969-985.
20. Prasad, R. N.; Bariana, D. S.; Fung, A.; Savic, M.; Tietje, K.; Stein, H. H.; Brondyk, H. D.; Egan, R. S. Modification of the 5′-position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5′-(N-substituted)carboxamides. J. Med. Chem. 1980, 23, 313-319.
21. 2 receptors. J. Med. Chem. 1986, 29, 1683-1689.
22. Bald, E.; Saigo, K.; Mukaiyama, T. A facile synthesis of carboxamides by using 1-methyl-2-halopyridinium iodides as coupling reagents. Chem. Lett. 1975, 1163-1166.
23. 2b receptor from human brain. Biochem. Biophys. Res. Comm. 1992, 187, 86-93.
24. Ha, S. B.; Nair, V. An improved approach to the synthesis of adenosine-5′-N-ethyluronamides of interest as adenosine receptor agonists. Tetrahedron Lett. 1996, 37, 1567-1570.
25. 35S]thio)triphosphate binding. Mol. Pharmacol. 1993, 44, 115-123.
26. 2 receptors. Can. J. Physiol. Pharmacol. 1986, 65, 365-376.
27. 1 receptors. J. Med. Chem. 1996, 39, 1463-1471.
28. 1 receptor. J Med. Chem. 1998, 41, 102-108.
29. Moos, W. H.; Hamilton, H. W.; Ortwine, D. F.; Taylor, M. D.; McPhail, A. T. Adenosine receptor agonists. X-ray crystal structure of NECA 1-(6-amino-9H-purin-9-yl)-1-deoxy-N-ethyl-β-D-ribofuranuronamide. Nucleosides Nucleotides 1989, 8, 449-461.
30. Nicklaus, M. C.; Wang, S.; Driscoll, J. S.; Milne, G. W. A. Conformational changes of small molecules binding to proteins. Bioorg. Med. Chem. 1995, 3, 411-428.
31. Bruns, R. F. Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol. 1980, 58, 673-691.
32. 1H NMR study of the syn-anti dynamic equilibrium in adenine nucleosides and nucleotides with the aid of some synthetic model analogues with fixed conformations. Z. Naturforsch. 1979, 34C, 359-373.
33. 1 receptor antagonists: further evidence for adenosine's anti mode of binding. Nucleosides Nucleotides 1990, 9, 275-291.
34. Stolarski, R.; Pohorille, A.; Dudycz, L.; Shugar, D. Comparison of theoretical and experimental approaches to determination of conformation of nucleosides about the glycosidic bond. Biochim. Biophys. Acta 1980, 610, 1-19.
35. Evans, F. E.; Kaplan, N. O. 8-Alkylaminoadenyl nucleotides as probes of dehydrogenase interactions with nucleotide analogues of different glycosyl conformation. J. Biol. Chem. 1976, 251, 6791-6797.
36. Birnbaum, G. I.; Shugar, D. Biologically active nucleosides and nucleotides: conformational features and interactions with enzymes. In Nucleic acid structure Part 3, Topics in molecular and structural biology; Neidle, S., Ed.; VCH Weinheim: New York, 1987; pp 1-70.
37. 6-(ω-aminoalkyl)-adenosines on adenosine receptor affinity and intrinsic activity. Eur. J. Pharmacol. 1989, 172, 185-193.
38. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 1989, 251, 888-893.
39. 3 adenosine receptor. Mol. Pharmacol. 1994, 45, 1101-1111.
40. Sheldrick, G. M. SHELXS97 Program for crystal structure determination; University of Göttingen: Germany, 1997.
41. Sheldrick, G. M. SHELXL-97-2 Program for crystal structure refinement; University of Göttingen: Germany, 1997.
42. Klooster, W. T.; Ruble, J. R.; Craven, B. M.; McMullan, R. K. Structure and thermal vibrations of adenosine from neutron diffraction data at 123 K. Acta Crystallogr. 1991, B47, 376-383.
43. Allen, F. H.; Kennard, O. 3D Search and research using the Cambridge Structural Database. Chemical Design Automation News 1993, 8, 1 and 31-37.
44. 2b adenosine receptor in NIH 3T3 fibroblasts. Biochem. Pharmacol. 1994, 47, 801-814.
45. 2b receptors evoke interleukin-8 secretion in human mast cells - An enprofylline-sensitive mechanism with implications for asthma. J. Clin. Invest. 1995, 96, 1979-1986.
46. 2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells. Br. J. Pharmacol. 1996, 119, 1286-1290.
47. 2B receptors. Pharmacol. Rev. 1997, 49, 381-402.
48. Spek, A. L. Acta Crystallogr. 1990, A46, C-34.